Inhibition of PAI-1 Activity by Toddalolactone as a Mechanism for Promoting Blood Circulation and Removing Stasis by Chinese Herb Zanthoxylum nitidum var. tomentosum

A novel selective inhibitor to thrombin-induced platelet aggregation purified from the leech Whitmania pigra

(2016) Xuan Liu et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Anti-coagulant therapy with dabigatran for cystic fibrosis patients

(2016) Manvi Bansal et al.   PEDIATRIC PULMONOLOGY

Short-term Effect of Infliximab Is Reflected in the Clot Lysis Profile of Patients with Inflammatory Bowel Disease

(2015) Lize Bollen et al.   INFLAMMATORY BOWEL DISEASES

Inhibitory effect of caffeic acid on ADP-induced thrombus formation and platelet activation involves mitogen-activated protein kinases

(2015) Yu Lu et al.   Scientific Reports

Functional Stability of Plasminogen Activator Inhibitor-1

(2014) Songul Yasar Yildiz et al.   TheScientificWorldJOURNAL

Antithrombotic Activity of a Newly Synthesized Coumarin Derivative 3-(5-Hydroxy-2,2-dimethyl-chroman-6-yl)-N-{2-[3-(5-hydroxy-2,2-dimethyl-chroman-6-yl)-propionylamino]-ethyl}-propionamide

(2013) Manish Jain et al.   Chemical Biology & Drug Design

Tanshinones Increase Fibrinolysis through Inhibition of Plasminogen Activator Inhibitor-1

(2012) Ying-Hong Xiao et al.   CNS Neuroscience & Therapeutics

PAI-1 in tissue fibrosis

(2011) Asish K. Ghosh et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Chemical Constituents, Antimicrobial and Antimalarial Activities ofZanthoxylum monophyllum

(2011) Raquel Rodríguez-Guzmán et al.   PLANTA MEDICA

A Novel Inhibitor of Plasminogen Activator Inhibitor-1 Provides Antithrombotic Benefits Devoid of Bleeding Effect in Nonhuman Primates

(2010) Yuko Izuhara et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Effect of tiplaxtinin (PAI-039), an orally bioavailable PAI-1 antagonist in a rat model of thrombosis

(2008) J. K. Hennan et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS